Home » TAIWAN TO CURB OVER-PRESCRIPTION OF REIMBURSABLE DRUGS
TAIWAN TO CURB OVER-PRESCRIPTION OF REIMBURSABLE DRUGS
August 10, 2005
Taiwan's Bureau of National Health Insurance (NHI) has announced that it will no longer reimburse a number of medicines that it considers are over-prescribed. The NHI plans to bring in a quota system for prescriptions in order to regulate costs.
Among the targeted drugs are two anti-coagulants, Ticilid and Plavix. It is estimated that around 10% of doctors frequently prescribe these drugs to over 67% of their patients.
New NHI regulations will mean that doctors are not reimbursed for prescribing
the drugs past the 67% limit. Reimbursement will also be withdrawn if doctors
prescribe antibiotics to more than 30% of their patients each month.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct